CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$45.15 -4.89 (-9.77%)
At close: Nov 10, 2026 · 4:00 PM EST

CRISPR Therapeutics AG (CRSP) Other Operating Expenses (2020 - 2026)

Updated

CRISPR Therapeutics AG (CRSP) posted Other Operating Expenses of $124.85 million for Q3 2026, up 7.6% from $116.02 million a year earlier and up 13.6% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Other Operating Expenses (2020 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Other Operating Expenses at CRISPR Therapeutics AG was $486.5 million, down 9.8% year-over-year; for FY2025, it came in at $594.54 million, up 38.0% from FY2024.

  • Annual Other Operating Expenses shows a five-year compound annual growth rate of 17.2% (FY2020 to FY2025).
  • In prior years, CRISPR Therapeutics AG's Other Operating Expenses was $430.9 million in FY2024 (-16.7%), $517.58 million in FY2023 (-9.5%), $571.9 million in FY2022 (+29.5%) and $441.75 million in FY2021 (+64.0%).
  • Quarterly Other Operating Expenses has run from a low of $82.16 million in Q4 2024 to a high of $211.3 million in Q2 2025 over five years.
  • On a year-over-year basis, Other Operating Expenses increased in five of the last eight quarters, with growth averaging 9.5%.
  • The strongest year-over-year quarter for Other Operating Expenses in the past five years was Q4 2025, with growth of 67.0%; the weakest was Q2 2026, with a decline of 48.0%.
  • According to Business Quant data, Other Operating Expenses for the three prior quarters was $109.9 million (Q2 2026), $114.52 million (Q1 2026) and $137.23 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CRISPR Therapeutics AG 4.37 Bn -4.68 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 52.96 Mn
Jun 30, 2026 42.75 Mn
Mar 31, 2026 45.95 Mn
Dec 31, 2025 53.70 Mn
Sep 30, 2025 57.12 Mn
Jun 30, 2025 141.41 Mn
Mar 31, 2025 57.51 Mn
Dec 31, 2024 10.42 Mn
Sep 30, 2024 11.15 Mn
Jun 30, 2024 52.13 Mn
Mar 31, 2024 46.97 Mn
Dec 31, 2023 20.00 Mn
Sep 30, 2023 23.42 Mn
Jun 30, 2023 44.64 Mn
Mar 31, 2023 42.19 Mn
Dec 31, 2022 6.82 Mn
Sep 30, 2022 38.86 Mn
Jun 30, 2022 33.92 Mn
Mar 31, 2022 30.65 Mn
Dec 31, 2021 31.82 Mn
API Access

CRISPR Therapeutics AG Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CRSP&period=max&api_key=YOUR_API_KEY